Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer

Molecular Pharmaceutics

Volumn 13, Issue 6, 2016, Pages 2049-2058

  Patel, Ketan ^a   Doddapaneni, Ravi ^a   Sekar, Vasanthakumar ^a   Chowdhury, Nusrat ^a   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

docetaxel; EphA2 receptor; extracellular matrix (ECM); orthotopic lung cancer; PEGylated liposomes; targeted drug delivery

Indexed keywords

COLLAGEN; CYCLINE; DOCETAXEL; EPHRIN RECEPTOR A2; LIPOSOME; NANOCARRIER; NICKEL; PHOSPHOLIPID; TELMISARTAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UVOMORULIN; ANTINEOPLASTIC AGENT; CADHERIN; DRUG CARRIER; GELATINASE B; MACROGOL DERIVATIVE; PEPTIDE; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CAVEOLA; CELL TRANSPORT; CHELATION; CONCENTRATION (PARAMETERS); DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENTIATION; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; HYDRATION; HYDRODYNAMICS; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; LUNG CANCER; LUNG TUMOR; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TREATMENT DURATION; TUMOR VOLUME; WESTERN BLOTTING; XENOGRAFT; A-549 CELL LINE; ANIMAL; CHEMISTRY; LUNG NEOPLASMS; METABOLISM; NUDE MOUSE; PROCEDURES; TUMOR CELL LINE;

A549 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; CADHERINS; CELL LINE, TUMOR; COLLAGEN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LIPOSOMES; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; PEPTIDES; POLYETHYLENE GLYCOLS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPHA2; TAXOIDS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84973622067     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.6b00187     Document Type: Article

References (47)

1. Fulzele, S. V.; Chatterjee, A.; Shaik, M. S.; Jackson, T.; Ichite, N.; Singh, M. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors Anti-Cancer Drugs 2007, 18 (1) 65-78 10.1097/CAD.0b013e3280101006
2. Fulzele, S. V.; Chatterjee, A.; Shaik, M. S.; Jackson, T.; Singh, M. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model Pharm. Res. 2006, 23 (9) 2094-106 10.1007/s11095-006-9074-6
3. Ichite, N.; Chougule, M. B.; Jackson, T.; Fulzele, S. V.; Safe, S.; Singh, M. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer Clin. Cancer Res. 2009, 15 (2) 543-52 10.1158/1078-0432.CCR-08-1558
4. Al-Abd, A. M.; Aljehani, Z. K.; Gazzaz, R. W.; Fakhri, S. H.; Jabbad, A. H.; Alahdal, A. M.; Torchilin, V. P. Pharmacokinetic strategies to improve drug penetration and entrapment within solid tumors J. Controlled Release 2015, 219, 269-77 10.1016/j.jconrel.2015.08.055
5. Bae, Y. H.; Park, K. Targeted drug delivery to tumors: myths, reality and possibility J. Controlled Release 2011, 153 (3) 198-205 10.1016/j.jconrel.2011.06.001
6. Jain, R. K.; Stylianopoulos, T. Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 2010, 7 (11) 653-64 10.1038/nrclinonc.2010.139
7. Lammers, T.; Kiessling, F.; Hennink, W. E.; Storm, G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Controlled Release 2012, 161 (2) 175-87 10.1016/j.jconrel.2011.09.063
8. Kobayashi, H.; Watanabe, R.; Choyke, P. L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 2014, 4 (1) 81-9 10.7150/thno.7193
9. Doddapaneni, R.; Patel, K.; Owaid, I. H.; Singh, M. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer Drug Delivery 2016, 1-10 10.3109/10717544.2015.1124472
10. Nag, O. K.; Awasthi, V. Surface engineering of liposomes for stealth behavior Pharmaceutics 2013, 5 (4) 542-69 10.3390/pharmaceutics5040542
11. Chang, H. I.; Yeh, M. K. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy Int. J. Nanomed. 2012, 7, 49-60 10.2147/IJN.S26766
12. Patel, K.; Patil, A.; Mehta, M.; Gota, V.; Vavia, P. Medium chain triglyceride (MCT) rich, paclitaxel loaded self nanoemulsifying preconcentrate (PSNP): a safe and efficacious alternative to Taxol J. Biomed. Nanotechnol. 2013, 9 (12) 1996-2006 10.1166/jbn.2013.1710
13. Patel, K.; Patil, A.; Mehta, M.; Gota, V.; Vavia, P. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity Int. J. Pharm. 2014, 472 (1-2) 214-23 10.1016/j.ijpharm.2014.06.031
14. Molina, J. R.; Yang, P.; Cassivi, S. D.; Schild, S. E.; Adjei, A. A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin. Proc. 2008, 83 (5) 584-94 10.1016/S0025-6196(11)60735-0
15. Brannan, J. M.; Sen, B.; Saigal, B.; Prudkin, L.; Behrens, C.; Solis, L.; Dong, W.; Bekele, B. N.; Wistuba, I.; Johnson, F. M. EphA2 in the early pathogenesis and progression of non-small cell lung cancer Cancer Prev. Res. 2009, 2 (12) 1039-49 10.1158/1940-6207.CAPR-09-0212
16. Brannan, J. M.; Dong, W.; Prudkin, L.; Behrens, C.; Lotan, R.; Bekele, B. N.; Wistuba, I.; Johnson, F. M. Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer Clin. Cancer Res. 2009, 15 (13) 4423-30 10.1158/1078-0432.CCR-09-0473
17. Patel, A. R.; Chougule, M.; Singh, M. EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer Pharm. Res. 2014, 31 (10) 2796-809 10.1007/s11095-014-1377-4
18. Xi, H. Q.; Wu, X. S.; Wei, B.; Chen, L. Eph receptors and ephrins as targets for cancer therapy J. Cell Mol. Med. 2012, 16 (12) 2894-909 10.1111/j.1582-4934.2012.01612.x
19. Tandon, M.; Vemula, S. V.; Mittal, S. K. Emerging strategies for EphA2 receptor targeting for cancer therapeutics Expert Opin. Ther. Targets 2011, 15 (1) 31-51 10.1517/14728222.2011.538682
20. Wang, S.; Noberini, R.; Stebbins, J. L.; Das, S.; Zhang, Z.; Wu, B.; Mitra, S.; Billet, S.; Fernandez, A.; Bhowmick, N. A.; Kitada, S.; Pasquale, E. B.; Fisher, P. B.; Pellecchia, M. Targeted delivery of paclitaxel to EphA2-expressing cancer cells Clin. Cancer Res. 2013, 19 (1) 128-37 10.1158/1078-0432.CCR-12-2654
21. Wang, S.; Placzek, W. J.; Stebbins, J. L.; Mitra, S.; Noberini, R.; Koolpe, M.; Zhang, Z.; Dahl, R.; Pasquale, E. B.; Pellecchia, M. Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells J. Med. Chem. 2012, 55 (5) 2427-36 10.1021/jm201743s
22. Minchinton, A. I.; Tannock, I. F. Drug penetration in solid tumours Nat. Rev. Cancer 2006, 6 (8) 583-92 10.1038/nrc1893
23. Netti, P. A.; Berk, D. A.; Swartz, M. A.; Grodzinsky, A. J.; Jain, R. K. Role of extracellular matrix assembly in interstitial transport in solid tumors Cancer Res. 2000, 60 (9) 2497-503
24. Chauhan, V. P.; Martin, J. D.; Liu, H.; Lacorre, D. A.; Jain, S. R.; Kozin, S. V.; Stylianopoulos, T.; Mousa, A. S.; Han, X.; Adstamongkonkul, P.; Popovic, Z.; Huang, P.; Bawendi, M. G.; Boucher, Y.; Jain, R. K. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels Nat. Commun. 2013, 4, 2516 10.1038/ncomms3516
25. Kanapathipillai, M.; Mammoto, A.; Mammoto, T.; Kang, J. H.; Jiang, E.; Ghosh, K.; Korin, N.; Gibbs, A.; Mannix, R.; Ingber, D. E. Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix Nano Lett. 2012, 12 (6) 3213-7 10.1021/nl301206p
26. Murty, S.; Gilliland, T.; Qiao, P.; Tabtieng, T.; Higbee, E.; Al Zaki, A.; Pure, E.; Tsourkas, A. Nanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model Part. Part. Syst. Charact. 2014, 31 (12) 1307-1312 10.1002/ppsc.201400169
27. Tredan, O.; Galmarini, C. M.; Patel, K.; Tannock, I. F. Drug resistance and the solid tumor microenvironment J. Natl. Cancer Inst 2007, 99 (19) 1441-54 10.1093/jnci/djm135
28. Cemazar, M.; Golzio, M.; Sersa, G.; Escoffre, J. M.; Coer, A.; Vidic, S.; Teissie, J. Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors Hum. Gene Ther. 2012, 23 (1) 128-37 10.1089/hum.2011.073
29. Guedan, S.; Rojas, J. J.; Gros, A.; Mercade, E.; Cascallo, M.; Alemany, R. Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth Mol. Ther. 2010, 18 (7) 1275-83 10.1038/mt.2010.79
30. Godugu, C.; Patel, A. R.; Doddapaneni, R.; Marepally, S.; Jackson, T.; Singh, M. Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models J. Controlled Release 2013, 172 (1) 86-95 10.1016/j.jconrel.2013.06.036
31. Xu, S.; Olenyuk, B. Z.; Okamoto, C. T.; Hamm-Alvarez, S. F. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances Adv. Drug Delivery Rev. 2013, 65 (1) 121-38 10.1016/j.addr.2012.09.041
32. dos Santos, T.; Varela, J.; Lynch, I.; Salvati, A.; Dawson, K. A. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines PLoS One 2011, 6 (9) e24438 10.1371/journal.pone.0024438
33. Chougule, M.; Patel, A. R.; Sachdeva, P.; Jackson, T.; Singh, M. Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer Lung Cancer 2011, 71 (3) 271-82 10.1016/j.lungcan.2010.06.002
34. Ichite, N.; Chougule, M.; Patel, A. R.; Jackson, T.; Safe, S.; Singh, M. Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer Mol. Cancer Ther. 2010, 9 (11) 3003-14 10.1158/1535-7163.MCT-09-1104
35. Jackson, T.; Chougule, M. B.; Ichite, N.; Patlolla, R. R.; Singh, M. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model Cancer Chemother. Pharmacol. 2008, 63 (1) 117-26 10.1007/s00280-008-0720-z
36. Patel, K.; Chowdhury, N.; Doddapaneni, R.; Boakye, C. H.; Godugu, C.; Singh, M. Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer J. Pharm. Sci. 2015, 104 (12) 4417-26 10.1002/jps.24637
37. Jin, S. E.; Jin, H. E.; Hong, S. S. Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics BioMed Res. Int. 2014, 2014, 814208 10.1155/2014/814208
38. Chikh, G. G.; Li, W. M.; Schutze-Redelmeier, M. P.; Meunier, J. C.; Bally, M. B. Attaching histidine-tagged peptides and proteins to lipid-based carriers through use of metal-ion-chelating lipids Biochim. Biophys. Acta, Biomembr. 2002, 1567 (1-2) 204-12 10.1016/S0005-2736(02)00618-1
39. Faham, A.; Altin, J. G. Ag-bearing liposomes engrafted with peptides that interact with CD11c/CD18 induce potent Ag-specific and antitumor immunity Int. J. Cancer 2011, 129 (6) 1391-403 10.1002/ijc.25810
40. Faham, A.; Bennett, D.; Altin, J. G. Liposomal Ag engrafted with peptides of sequence derived from HMGB1 induce potent Ag-specific and anti-tumour immunity Vaccine 2009, 27 (42) 5846-54 10.1016/j.vaccine.2009.07.053
41. Anikeeva, N.; Sykulev, Y.; Delikatny, E. J.; Popov, A. V. Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents Am. J. Nucl. Med. Mol. Imaging 2014, 4 (6) 507-24
42. Scarberry, K. E.; Dickerson, E. B.; McDonald, J. F.; Zhang, Z. J. Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells J. Am. Chem. Soc. 2008, 130 (31) 10258-62 10.1021/ja801969b
43. Wang, J. L.; Liu, Y. L.; Li, Y.; Dai, W. B.; Guo, Z. M.; Wang, Z. H.; Zhang, Q. EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats Invest. Ophthalmol. Visual Sci. 2012, 53 (11) 7348-57 10.1167/iovs.12-9955
44. Wykosky, J.; Gibo, D. M.; Debinski, W. A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells Mol. Cancer Ther. 2007, 6 (12) 3208-18 10.1158/1535-7163.MCT-07-0200
45. Dutta, D.; Donaldson, J. G. Search for inhibitors of endocytosis: Intended specificity and unintended consequences Cell Logist 2012, 2 (4) 203-208 10.4161/cl.23967
46. Shete, H. K.; Prabhu, R. H.; Patravale, V. B. Endosomal escape: a bottleneck in intracellular delivery J. Nanosci. Nanotechnol. 2014, 14 (1) 460-74 10.1166/jnn.2014.9082
47. Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Targeting of drugs and nanoparticles to tumors J. Cell Biol. 2010, 188 (6) 759-68 10.1083/jcb.200910104